Going further
for patients

ANNUAL REPORT 2015

Download PDF 4.2MB

HIGHLIGHTS
2015

1 APRIL 2015
Signature of a new Research Alliance agreement with
Harvard University
Download PDF 57KB
1 APRIL 2015
Inauguration of Ipsen R&D center in Cambridge
Download PDF 72KB
8 APRIL 2015
Signature of a joint research program
with Hannover
Medical School (Germany)
Download PDF 239KB
19 MAY 2015
Acquisition of OctreoPharm
Sciences
Download PDF 80KB
16 JULY 2015
Approval of Dysport®
as a treatment for
adult upper-limb spasticity in the US
Download PDF 102KB
3 AUGUST 2015
Positive results of telotristat etiprate
Download PDF 297KB
6 JANUARY 2016
Expansion of Ipsen and Galderma neurotoxin partnership
Download PDF 73KB
8 JANUARY 2016
Signature of a partnership with Belgium’s Aepodia
Link
17 FEBRUARY 2016
Signature of a licensing deal with 3B Pharmaceuticals
Download PDF 300KB
1 MARCH 2016
Signature of an exclusive licensing agreement
with Exelixis
Download PDF 158KB
8 MARCH 2016
Signature of a research partnership with PeptiMimesis
Download PDF 1MB

Interview
with
Marc de Garidel

More
results

More
innovation

Ipsen
worldwide